Correlation Between Kamada and Clal Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kamada and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kamada and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kamada and Clal Biotechnology Industries, you can compare the effects of market volatilities on Kamada and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kamada with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kamada and Clal Biotechnology.

Diversification Opportunities for Kamada and Clal Biotechnology

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kamada and Clal is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Kamada and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Kamada is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kamada are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Kamada i.e., Kamada and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Kamada and Clal Biotechnology

Assuming the 90 days trading horizon Kamada is expected to generate 0.7 times more return on investment than Clal Biotechnology. However, Kamada is 1.43 times less risky than Clal Biotechnology. It trades about 0.12 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.01 per unit of risk. If you would invest  198,000  in Kamada on November 3, 2024 and sell it today you would earn a total of  45,500  from holding Kamada or generate 22.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kamada  vs.  Clal Biotechnology Industries

 Performance 
       Timeline  
Kamada 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kamada may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kamada and Clal Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kamada and Clal Biotechnology

The main advantage of trading using opposite Kamada and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kamada position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.
The idea behind Kamada and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk